ImmuPharma Share Price (IMM)

122.75 +4.75 (+4.03%) delayed: 1:10PM GMT
Bid price 122.50 Open price 118.00
Ask price 123.00 Prev close 118.00
High price 126.25 Spread 0.41%
Low price 118.00 Volume 638,726

Register now for FREE live ImmuPharma share prices, ImmuPharma stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get ImmuPharma Level 2 Data, indepth research tools and investor commentary for ImmuPharma (IMM) and other London Stock Exchange equities.

ImmuPharma Share Price Chart

Advanced Charts >>

Register now for FREE ImmuPharma share price charts

ImmuPharma Share Price Information

Name ImmuPharma Epic IMM
Sector Pharmaceuticals & Biotechnology ISIN GB0033711010
Activites ImmuPharma PLC (formerly General Industries PLC) is developing innovative therapies for specialist diseases, It is headquartered in London and has its research operations in France (ImmuPharma (France) SA) and Switzerland (ImmuPharma AG). ImmuPharma is dedicated to the development of innovative drugs to treat serious medical conditions, characterised by: High unmet medical need; Low marketing costs; Relatively low development costs.. Founded first in Basel, Switzerland in 1999 and led by an experienced management team, ImmuPharma now has important R&D collaboration arrangements with highly respected health and medical research laboratories in Europe. The company plans either to bring its drug candidates to market itself, or to license them in corporate deals to other pharmaceutical companies. Index n/a

ImmuPharma Key Numbers

Latest Share Price (p) 122.75 Net Gearing (%) -10.63
Market Capitalisation (£m) 164.57 Gross Gearing (%) 17.35
Shares in issue (m) 139.47 Debt Ratio 3.80
P/E Ratio -25.99 Debt-to-Equity Ratio 0.19
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.21
Dividend Yield (%) 0.00 Price to book value 29.65
Dividend cover (x) 0.00 ROCE (%) -109.55
Earning per share (p) -4.54 EPS Growth (%) -3.18
52 week high / low 193.00 / 44.00 DPS Growth (%) n/a

ImmuPharma Director Deals

Dec.Date Type Director Pos No. of Shares
28/01/2013 SELL Dr Ajay Agrawal RES 62,129
24/01/2012 BUY Dr Franco Di Muzio NED 60,950
24/01/2012 BUY Dr Ajay Agrawal RES 62,169
23/07/2009 SELL Richard Warr RES 6,250,000
23/07/2009 SELL Dimitri Dimitriou CEO 6,250,000

More ImmuPharma Director Deals >>

ImmuPharma Company News

07:00 15/02/2018

London Investor Evening

RNS Number : 9140E Immupharma PLC 15 February 2018   15 February 2018     ImmuPharma PLC ("ImmuPharma" or the "Company")   London Investor Evening Monday 26 February 2018 @ 6pm   ImmuPharma PLC (LSE:...

14:00 09/02/2018

Holding(s) in Company

RNS Number : 4832E Immupharma PLC 09 February 2018                                                                                                                                     9 February 2018   ImmuPharma PLC ("ImmuPharma" or the "Company")...

09:35 07/02/2018

Holding(s) in Company

RNS Number : 1713E Immupharma PLC 07 February 2018   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i...

More ImmuPharma Company News >>

Register now for FREE ImmuPharma company news

ImmuPharma Share Price Discussions

27 days ago

IMMUPHARMA - small bio, big potential (IMM)

From today's Times: Tiddler to watch "ImmuPharma, steady at 46p, the biotech group which has a treatment of the disease Lupus in phase II trials, could benefit from the failure this week of trials of rival drug Rituxan. ImmuPharma's housebroker, Panmure Gordon, believes its client may attract...

Register now for FREE ImmuPharma share price discussions